Exact Mass: 696.3179312

Exact Mass Matches: 696.3179312

Found 95 metabolites which its exact mass value is equals to given mass value 696.3179312, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Thalicarpin

Thalicarpine

C41H48N2O8 (696.3410488000001)


C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product > C932 - Vinca Alkaloid Compound C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent C1907 - Drug, Natural Product

   
   

Olitorin

7,11-dihydroxy-5-[(4-hydroxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-15-methyl-14-(5-oxo-2,5-dihydrofuran-3-yl)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecane-2-carbaldehyde

C35H52O14 (696.3356891999999)


Isolated from Corchorus olitorius (Jews mallow). Olitorin is found in tea, herbs and spices, and green vegetables. Olitorin is found in green vegetables. Olitorin is isolated from Corchorus olitorius (Jews mallow D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides

   
   
   
   
   
   

2,4-Dihydroxy-6-methoxy-3-(2-hydroxybenzyl)-5-(3 x 2-hydroxybenzyl)dihydrochalcone

2,4-Dihydroxy-6-methoxy-3-(2-hydroxybenzyl)-5-(3 x 2-hydroxybenzyl)dihydrochalcone

C44H40O8 (696.2723040000001)


   

rel-(2R,3S,6R,7S,8S,9S,13R,14S,15S)-(4E,11E)-8,14,15-triacetoxy-3-(benzoyloxy)-6,9-epoxy-9-hydroxy-7-(tigloyloxy)jatropha-4,11-diene

rel-(2R,3S,6R,7S,8S,9S,13R,14S,15S)-(4E,11E)-8,14,15-triacetoxy-3-(benzoyloxy)-6,9-epoxy-9-hydroxy-7-(tigloyloxy)jatropha-4,11-diene

C38H48O12 (696.3145608)


   
   

5-Demethoxy,8-methoxy-2,2,3,3-Tetrahydro-3,3,6,7,7,8-hexamethoxy-4-(4-methoxyphenyl)-4-phenyl-5,6-bi-1H-phenalene,

5-Demethoxy,8-methoxy-2,2,3,3-Tetrahydro-3,3,6,7,7,8-hexamethoxy-4-(4-methoxyphenyl)-4-phenyl-5,6-bi-1H-phenalene,

C45H44O7 (696.3086874)


   

4-dehydrosarmentogenin rhamnoglucoside

4-dehydrosarmentogenin rhamnoglucoside

C35H52O14 (696.3356891999999)


   
   

Erysimoside

Erysimoside

C35H52O14 (696.3356891999999)


A cardenolide glycoside that consists of strophanthidin having a beta-D-glucopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl moiety attached at position 3. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides

   

3,5-Bis[[2,6-dihydroxy-4-methoxy-3-methyl-5-(2-methylpropanoyl)phenyl]methyl]-2-hydroxy-3,5-dimethyl-1-(2-methylpropanoyl)-1-cyclohexene-4,6-dione

3,5-Bis[[2,6-dihydroxy-4-methoxy-3-methyl-5-(2-methylpropanoyl)phenyl]methyl]-2-hydroxy-3,5-dimethyl-1-(2-methylpropanoyl)-1-cyclohexene-4,6-dione

C38H48O12 (696.3145608)


   
   

1-cinnamoyl-11-methoxymeliacarpinin

1-cinnamoyl-11-methoxymeliacarpinin

C37H44O13 (696.2781774)


   

16,17-dihydroneridienone 3-O-beta-D-glucopyranosyl-(1 -> 6)-O-beta-D-galactopyranoside

16,17-dihydroneridienone 3-O-beta-D-glucopyranosyl-(1 -> 6)-O-beta-D-galactopyranoside

C35H52O14 (696.3356891999999)


   
   
   
   
   
   
   

19-(formyl<*>carboxy)erysimin 4-O-alpha-L-rhamnopyranoside|3-O-alpha-L-rhamnopyranosyl-(1->4)-beta-D-digitoxopyranosyl cheiranthidin|cheiranthoside X|cheiranthoside XI

19-(formyl<*>carboxy)erysimin 4-O-alpha-L-rhamnopyranoside|3-O-alpha-L-rhamnopyranosyl-(1->4)-beta-D-digitoxopyranosyl cheiranthidin|cheiranthoside X|cheiranthoside XI

C35H52O14 (696.3356891999999)


   

2,2,3,3-Tetrahydro-3,3,6,7,7,8-hexamethoxy-4-(4-methoxyphenyl)-4-phenyl-5,6-bi[1H-phenalene]

2,2,3,3-Tetrahydro-3,3,6,7,7,8-hexamethoxy-4-(4-methoxyphenyl)-4-phenyl-5,6-bi[1H-phenalene]

C45H44O7 (696.3086874)


   

3beta-(O4(?)-beta-D-Glucopyranosyl-beta-D-glucopyranosyloxy)-14-hydroxy-14beta-carda-5,20(22)-dienolid|3beta-(O4(?)-beta-D-glucopyranosyl-beta-D-glucopyranosyloxy)-14-hydroxy-14beta-carda-5,20(22)-dienolide

3beta-(O4(?)-beta-D-Glucopyranosyl-beta-D-glucopyranosyloxy)-14-hydroxy-14beta-carda-5,20(22)-dienolid|3beta-(O4(?)-beta-D-glucopyranosyl-beta-D-glucopyranosyloxy)-14-hydroxy-14beta-carda-5,20(22)-dienolide

C35H52O14 (696.3356891999999)


   

beta-Phenyl-2,4-dihydroxy-3-[2-hydroxy-5-[2-hydroxy-3-(2-hydroxybenzyl)benzyl]benzyl]-5-(2-hydroxybenzyl)-6-methoxypropiophenone

beta-Phenyl-2,4-dihydroxy-3-[2-hydroxy-5-[2-hydroxy-3-(2-hydroxybenzyl)benzyl]benzyl]-5-(2-hydroxybenzyl)-6-methoxypropiophenone

C44H40O8 (696.2723040000001)


   

9-{6-[(6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]-2,3-dimethoxyphenoxy}-1,2,10-trimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline

9-{6-[(6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]-2,3-dimethoxyphenoxy}-1,2,10-trimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline

C41H48N2O8 (696.3410488000001)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.738 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.733

   

C35H52O14_Carda-5,20(22)-dienolide, 3-[(2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-14-hydroxy-, (3beta)

NCGC00385195-01_C35H52O14_Carda-5,20(22)-dienolide, 3-[(2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-14-hydroxy-, (3beta)-

C35H52O14 (696.3356891999999)


   

C35H52O14_Carda-5,17-dienolide, 3-[(3-O-hexopyranosylhexopyranosyl)oxy]-14-hydroxy-, (17E)

NCGC00384532-01_C35H52O14_Carda-5,17-dienolide, 3-[(3-O-hexopyranosylhexopyranosyl)oxy]-14-hydroxy-, (17E)-

C35H52O14 (696.3356891999999)


   

Thaliblastine

Thaliblastine

C41H48N2O8 (696.3410488000001)


Formula(Parent): C41H48N2O8; Origin: Plant; Bottle Name:Thalicarpine hydrochloride; PRIME Parent Name:Thalicarpine; PRIME in-house No.:V0344; SubCategory_DNP: Isoquinoline alkaloids, Benzylisoquinoline alkaloids Origin: Plant; Formula(Parent): C41H48N2O8; Bottle Name:Thalicarpine hydrochloride; PRIME Parent Name:Thalicarpine; PRIME in-house No.:V0344; SubCategory_DNP: Isoquinoline alkaloids, Benzylisoquinoline alkaloids

   

Olitoriside

Olitoriside

C35H52O14 (696.3356891999999)


Origin: Plant, Cardanolides

   

Olitorin

7,11-dihydroxy-5-[(4-hydroxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-15-methyl-14-(5-oxo-2,5-dihydrofuran-3-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecane-2-carbaldehyde

C35H52O14 (696.3356891999999)


D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides

   

OOV-PI

1-(9Z-octadecenoyl)-2-(5-oxo-valeroyl)-sn-glycero-3-phospho-(1-myo-inositol)

C32H57O14P (696.3485751999999)


   
   

Candesartan methyl ester N1-trityl analog

Candesartan methyl ester N1-trityl analog

C44H36N6O3 (696.2848746)


   

2-benzofuran-1,3-dione,2-hydroxyethyl prop-2-enoate,methyl 2-methylprop-2-enoate,oxiran-2-ylmethyl 7,7-dimethyloctanoate,styrene

2-benzofuran-1,3-dione,2-hydroxyethyl prop-2-enoate,methyl 2-methylprop-2-enoate,oxiran-2-ylmethyl 7,7-dimethyloctanoate,styrene

C39H52O11 (696.3509442000001)


   

N,N-Bis(11-hydroxyundecanyl)bipyridinium diperchlorate (Viologen)

N,N-Bis(11-hydroxyundecanyl)bipyridinium diperchlorate (Viologen)

C32H54Cl2N2O10 (696.3155324)


   

NY IV34 1

4H-Dibenzo(de,g)quinoline, 9-(4,5-dimethoxy-2-((1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl)methyl)phenoxy)-5,6,6a,7-tetrahydro-1,2,10-trimethoxy-6-methyl-, (S-(R*,R*))- (9CI)

C41H48N2O8 (696.3410488000001)


C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product > C932 - Vinca Alkaloid Compound C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent C1907 - Drug, Natural Product

   

rifamycin SV(1-)

rifamycin SV(1-)

C37H46NO12- (696.3019856000001)


A phenolate anion obtained by deprotonation of the 5-hydroxy group of rifamycin SV. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

   

(8xi,9xi,14xi,17xi)-3-{[(4xi)-2,6-dideoxy-4-O-(D-glucopyranosyl)-beta-D-erythro-hexopyranosyl]oxy}-5,14-dihydroxy-19-oxocard-20(22)-enolide

(8xi,9xi,14xi,17xi)-3-{[(4xi)-2,6-dideoxy-4-O-(D-glucopyranosyl)-beta-D-erythro-hexopyranosyl]oxy}-5,14-dihydroxy-19-oxocard-20(22)-enolide

C35H52O14 (696.3356891999999)


   

[(2S,3S,6S)-6-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

[(2S,3S,6S)-6-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C35H52O12S (696.3179312)


   

Thalicarpine

Thalicarpine

C41H48N2O8 (696.3410488000001)


C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product > C932 - Vinca Alkaloid Compound C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent C1907 - Drug, Natural Product

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(1r,2e,4r,5s,7s,8r,9s,10e,13s,14r,15s)-7,8,14-tris(acetyloxy)-13-hydroxy-1,5,9,12,12-pentamethyl-15-{[(2e)-2-methylbut-2-enoyl]oxy}-16-oxatricyclo[11.2.1.0³,⁷]hexadeca-2,10-dien-4-yl benzoate

(1r,2e,4r,5s,7s,8r,9s,10e,13s,14r,15s)-7,8,14-tris(acetyloxy)-13-hydroxy-1,5,9,12,12-pentamethyl-15-{[(2e)-2-methylbut-2-enoyl]oxy}-16-oxatricyclo[11.2.1.0³,⁷]hexadeca-2,10-dien-4-yl benzoate

C38H48O12 (696.3145608)


   

7-[(6-{[(4,6-dihydroxy-2-methyloxan-3-yl)oxy]methyl}-3,4,5-trihydroxyoxan-2-yl)oxy]-3a,5a-dihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde

7-[(6-{[(4,6-dihydroxy-2-methyloxan-3-yl)oxy]methyl}-3,4,5-trihydroxyoxan-2-yl)oxy]-3a,5a-dihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde

C35H52O14 (696.3356891999999)


   

4-{3-[(5-{[3,4-dihydroxy-6-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy]butyl}-3,5,5-trimethylcyclohex-2-en-1-one

4-{3-[(5-{[3,4-dihydroxy-6-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy]butyl}-3,5,5-trimethylcyclohex-2-en-1-one

C31H52O17 (696.3204342)


   

7,8,14-tris(acetyloxy)-13-hydroxy-1,5,9,12,12-pentamethyl-15-[(2-methylbut-2-enoyl)oxy]-16-oxatricyclo[11.2.1.0³,⁷]hexadeca-2,10-dien-4-yl benzoate

7,8,14-tris(acetyloxy)-13-hydroxy-1,5,9,12,12-pentamethyl-15-[(2-methylbut-2-enoyl)oxy]-16-oxatricyclo[11.2.1.0³,⁷]hexadeca-2,10-dien-4-yl benzoate

C38H48O12 (696.3145608)


   

{4,8,9-trihydroxy-6,16,18-trimethoxy-11-propyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl}methyl 2-(3-ethyl-2,5-dioxopyrrolidin-1-yl)benzoate

{4,8,9-trihydroxy-6,16,18-trimethoxy-11-propyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl}methyl 2-(3-ethyl-2,5-dioxopyrrolidin-1-yl)benzoate

C38H52N2O10 (696.3621772)


   

(1r,2r,3s,4r,5s,6s,8s,10s,11r,12r,15s)-3,4,6,11-tetrakis(acetyloxy)-2-hydroxy-1,5,15-trimethyl-9-methylidene-14-oxo-16-oxatetracyclo[10.5.0.0²,¹⁵.0⁵,¹⁰]heptadecan-8-yl (2e)-3-phenylprop-2-enoate

(1r,2r,3s,4r,5s,6s,8s,10s,11r,12r,15s)-3,4,6,11-tetrakis(acetyloxy)-2-hydroxy-1,5,15-trimethyl-9-methylidene-14-oxo-16-oxatetracyclo[10.5.0.0²,¹⁵.0⁵,¹⁰]heptadecan-8-yl (2e)-3-phenylprop-2-enoate

C37H44O13 (696.2781774)


   

3,4,6,11-tetrakis(acetyloxy)-2-hydroxy-1,5,15-trimethyl-9-methylidene-14-oxo-16-oxatetracyclo[10.5.0.0²,¹⁵.0⁵,¹⁰]heptadecan-8-yl 3-phenylprop-2-enoate

3,4,6,11-tetrakis(acetyloxy)-2-hydroxy-1,5,15-trimethyl-9-methylidene-14-oxo-16-oxatetracyclo[10.5.0.0²,¹⁵.0⁵,¹⁰]heptadecan-8-yl 3-phenylprop-2-enoate

C37H44O13 (696.2781774)


   

(1r,3as,3br,5as,7s,9ar,9bs,11ar)-3a-hydroxy-7-{[(2r,4s,5r,6r)-4-hydroxy-6-methyl-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-11a-methyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthrene-9a-carboxylic acid

(1r,3as,3br,5as,7s,9ar,9bs,11ar)-3a-hydroxy-7-{[(2r,4s,5r,6r)-4-hydroxy-6-methyl-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-11a-methyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthrene-9a-carboxylic acid

C35H52O14 (696.3356891999999)


   

(4r)-4-[(3s)-3-{[(2r,3r,4r,5s,6r)-5-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl]-3,5,5-trimethylcyclohex-2-en-1-one

(4r)-4-[(3s)-3-{[(2r,3r,4r,5s,6r)-5-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl]-3,5,5-trimethylcyclohex-2-en-1-one

C31H52O17 (696.3204342)


   

4-[(1r,3as,3br,7s,9ar,9bs,11ar)-7-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3a-hydroxy-9a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5h-furan-2-one

4-[(1r,3as,3br,7s,9ar,9bs,11ar)-7-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3a-hydroxy-9a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5h-furan-2-one

C35H52O14 (696.3356891999999)


   

3a-hydroxy-7-[(4-hydroxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-11a-methyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthrene-9a-carboxylic acid

3a-hydroxy-7-[(4-hydroxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-11a-methyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthrene-9a-carboxylic acid

C35H52O14 (696.3356891999999)


   

4,7-dihydroxy-1-(5-methyl-6-phenylhexyl)-6-[(6-methyl-9-phenylnon-4-enoyl)oxy]-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid

4,7-dihydroxy-1-(5-methyl-6-phenylhexyl)-6-[(6-methyl-9-phenylnon-4-enoyl)oxy]-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid

C38H48O12 (696.3145608)


   

(2s,5s,8s,14s,17s,20s)-14-benzyl-4,7,16,19-tetrahydroxy-2,5-diisopropyl-17-[(1r)-1-[(2-methylbut-3-en-2-yl)oxy]ethyl]-22-thia-3,6,12,15,18,23-hexaazatricyclo[18.2.1.0⁸,¹²]tricosa-1(23),3,6,15,18-pentaen-13-one

(2s,5s,8s,14s,17s,20s)-14-benzyl-4,7,16,19-tetrahydroxy-2,5-diisopropyl-17-[(1r)-1-[(2-methylbut-3-en-2-yl)oxy]ethyl]-22-thia-3,6,12,15,18,23-hexaazatricyclo[18.2.1.0⁸,¹²]tricosa-1(23),3,6,15,18-pentaen-13-one

C36H52N6O6S (696.3668852000001)


   

(1r,2e,4s,5s,7r,8s,9r,10e,13s,14s,15r)-7,8,14-tris(acetyloxy)-13-hydroxy-1,5,9,12,12-pentamethyl-15-{[(2e)-2-methylbut-2-enoyl]oxy}-16-oxatricyclo[11.2.1.0³,⁷]hexadeca-2,10-dien-4-yl benzoate

(1r,2e,4s,5s,7r,8s,9r,10e,13s,14s,15r)-7,8,14-tris(acetyloxy)-13-hydroxy-1,5,9,12,12-pentamethyl-15-{[(2e)-2-methylbut-2-enoyl]oxy}-16-oxatricyclo[11.2.1.0³,⁷]hexadeca-2,10-dien-4-yl benzoate

C38H48O12 (696.3145608)